Skip to content

Clinical trials

Phase 3 Acquired Immunodeficiency Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 3 Country / region: Canada Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20051
20061
20084
20102
20116
20132
20141
20152
20164
20181
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare13
Gilead Sciences4
Glaxo Wellcome3
Tibotec Pharmaceuticals, Ireland3
GlaxoSmithKline2
Janssen R&D Ireland2
Abbott1
Bristol-Myers Squibb1
Janssen Sciences Ireland UC1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome35
HIV Infections22
Infections8
AIDS-Related Complex2
Hepatitis C2
AIDS Dementia Complex1
Communicable Diseases1
Cytomegalovirus Infections1
Hepatitis B1
Hepatitis C, Chronic1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.